Attached files

file filename
EX-99.2 - PRESS RELEASE - Gemini Therapeutics, Inc. /DEea135023ex99-2_gemini.htm
EX-99.1 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Gemini Therapeutics, Inc. /DEea135023ex99-1_gemini.htm
EX-16.1 - WITHUM'S LETTER TO THE SECURITIES AND EXCHANGE COMMISSION, DATED FEBRUARY 11, 20 - Gemini Therapeutics, Inc. /DEea135023ex16-1_gemini.htm
EX-10.11 - EMPLOYMENT AGREEMENT, DATED JANUARY 22, 2021, BY AND BETWEEN GEMINI THERAPEUTICS - Gemini Therapeutics, Inc. /DEea135023ex10-11_gemini.htm
EX-10.10 - EMPLOYMENT AGREEMENT, DATED DECEMBER 24, 2020, BY AND BETWEEN GEMINI THERAPEUTIC - Gemini Therapeutics, Inc. /DEea135023ex10-10_gemini.htm
EX-10.9 - EMPLOYMENT AGREEMENT, DATED JANUARY 21, 2021, BY AND BETWEEN GEMINI THERAPEUTICS - Gemini Therapeutics, Inc. /DEea135023ex10-9_gemini.htm
EX-10.8 - FORM OF SUBSCRIPTION AGREEMENT - Gemini Therapeutics, Inc. /DEea135023ex10-8_gemini.htm
EX-10.7 - FORM OF INDEMNIFICATION AGREEMENT FOR EXECUTIVE OFFICERS OF GEMINI THERAPEUTICS, - Gemini Therapeutics, Inc. /DEea135023ex10-7_gemini.htm
EX-10.6 - FORM OF INDEMNIFICATION AGREEMENT FOR DIRECTORS OF GEMINI THERAPEUTICS, INC - Gemini Therapeutics, Inc. /DEea135023ex10-6_gemini.htm
EX-10.5 - FORMS OF AWARD AGREEMENTS UNDER THE GEMINI 2021 STOCK OPTION AND INCENTIVE PLAN - Gemini Therapeutics, Inc. /DEea135023ex10-5_gemini.htm
EX-10.4 - GEMINI 2021 STOCK OPTION AND INCENTIVE PLAN - Gemini Therapeutics, Inc. /DEea135023ex10-4_gemini.htm
EX-10.3 - LOCKUP AGREEMENT, DATED FEBRUARY 5, 2021, BY AND AMONG GEMINI THERAPEUTICS, INC. - Gemini Therapeutics, Inc. /DEea135023ex10-3_gemini.htm
EX-10.2 - VOTING AGREEMENT, DATED FEBRUARY 5, 2021, BY AND AMONG GEMINI THERAPEUTICS, INC. - Gemini Therapeutics, Inc. /DEea135023ex10-2_gemini.htm
EX-4.1 - FORM OF SPECIMEN COMMON STOCK CERTIFICATE - Gemini Therapeutics, Inc. /DEea135023ex4-1_gemini.htm
EX-3.2 - AMENDED AND RESTATED BY-LAWS OF GEMINI THERAPEUTICS, INC - Gemini Therapeutics, Inc. /DEea135023ex3-2_gemini.htm
EX-3.1 - AMENDED AND RESTATED ARTICLES OF CERTIFICATE OF INCORPORATION GEMINI THERAPEUTIC - Gemini Therapeutics, Inc. /DEea135023ex3-1_gemini.htm
EX-2.1 - MERGER AGREEMENT, DATED AS OF OCTOBER 15, 2020, BY AND AMONG GEMINI THERAPEUTICS - Gemini Therapeutics, Inc. /DEea135023ex2-1_gemini.htm
8-K - CURRENT REPORT - Gemini Therapeutics, Inc. /DEea135023-8k_geminitherap.htm

Exhibit 21.1

 

LIST OF SUBSIDIARIES

 

February 11, 2021

 

Name of Active Subsidiary   Jurisdiction
Gemini Therapeutics Sub, Inc. (100%)   Delaware

 

*Percentage in parentheses indicate Gemini Therapeutics, Inc.’s ownership